Case number 1:23-cv-00734
Actelion Pharmaceuticals Ltd et al v. Apotex Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 28, 2023 | 10 | PROPOSED CONSENT JUDGMENT AND PERMANENT INJUNCTION, by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc.. (Balick, Steven) (Entered: 09/28/2023) (3) |
| Sep 28, 2023 | 11 | CONSENT JUDGMENT AND ORDER OF PERMANENT INJUNCTION. Signed by Judge Colm F. Connolly on 9/28/2023. (nmf) (Entered: 09/28/2023) (3) |
| Sep 28, 2023 | 12 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,094,781. (Attachments: # 1 Consent Judgment and Order of Permanent Injunction)(nmf) (Entered: 09/28/2023) (0) |
| Sep 27, 2023 | 9 | NOTICE of Appearance by Kaan Ekiner on behalf of Apotex Corp., Apotex Inc. (Ekiner, Kaan) (Entered: 09/27/2023) (1) |
| Sep 14, 2023 | 7 | WAIVER OF SERVICE returned executed by Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd: For Apotex Inc. waiver sent on 9/7/2023, answer due 12/6/2023. (Mayo, Andrew) (Entered: 09/14/2023) (1) |
| Sep 14, 2023 | 8 | WAIVER OF SERVICE returned executed by Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd: For Apotex Corp. waiver sent on 9/7/2023, answer due 11/6/2023. (Mayo, Andrew) (Entered: 09/14/2023) (1) |
| Jul 12, 2023 | N/A | Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) (Entered: 07/12/2023) (0) |
| Jul 12, 2023 | 6 | STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf) (Entered: 07/12/2023) (2) |
| Jul 6, 2023 | 1 | Complaint* (1) |
| Jul 6, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 07/06/2023) (3) |
| Jul 6, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/30/2023 & 6/1/2023. Date of Expiration of Patent: 12/5/2025.Thirty Month Stay Deadline: 12/1/2025. (mpb) (Entered: 07/06/2023) (2) |
| Jul 6, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,094,781. (mpb) (Entered: 07/06/2023) (1) |
| Jul 6, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc. filed by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc.. (mpb) (Entered: 07/06/2023) (2) |
| Jul 6, 2023 | N/A | No Summons Issued. (mpb) (Entered: 07/06/2023) (0) |
